Advertisement

Topics

ChemDiv Inc. Company Profile

17:10 EST 22nd November 2017 | BioPortfolio

ChemDiv Inc. (Chemical Diversity) is a global chemistry-driven contract research organization focused on identifying and delivering discovery opportunities and services for life science partners, and merging industrial and academic efforts to bring new approaches to the treatment of life-threatening diseases. For further information please visit http://www.chemdiv.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

ChemDiv discovery platform tapped to advance R&D pipeline into preclinical studies

The Tri-Institutional Therapeutics Discovery Institute, Inc. will use ChemDiv's proprietary discovery chemistry platform to advance its research and development (R&D) pipeline.

ChemDiv Heads Three-Way Development Agreement for Neurodegenerative Diseases

Research will focus on Sigma1 dysfunction associated with early onset diseases, such as ALS and Alzheimer's

ChemDiv's Discovery Chemistry Platform to Help Advance Tri-Institutional Therapeutics Discovery ...

"Tri-I TDI strives to advance groundbreaking academic discoveries to preclinical studies in order to demonstrate their relevance in blocking disease initiation and progression. Our goal at Read m...

ChemDiv Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 26072017] Prices from USD $250

SummaryChemDiv Inc ChemDiv, a subsidiary of ChemRar HighTech Center is a contract research organization that offers chemistry services, hit finding, integrated drug discovery, pharmatech services, dis...

Regen BioPharma, Inc. Researchers Identify Key Structure in Compounds that Activate NR2F6

SAN DIEGO, September 6, 2017 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), in conjunction with its medicinal chemistry partner, ChemDiv, Inc., believes it has made a funda...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD Inhibitors.

p-Hydroxyphenylpyruvate dioxygenase (HPPD) is not only the useful molecular target in treating life-threatening tyrosinemia type I, but also an important target for chemical herbicides. A combined in ...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ChemDiv Inc.

ChemDiv Inc. (Chemical Diversity) is a global chemistry-driven contract research organization focused on identifying and delivering discovery opportunities and services for life science partners, ...

ChemDiv, Inc.

ChemDiv, Inc. (ChemDiv) is a global chemistry-driven contract research organization focused on the delivery of new scientific innovation and a range of products and services that meet the drug discove...

More Information about "ChemDiv Inc." on BioPortfolio

We have published hundreds of ChemDiv Inc. news stories on BioPortfolio along with dozens of ChemDiv Inc. Clinical Trials and PubMed Articles about ChemDiv Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ChemDiv Inc. Companies in our database. You can also find out about relevant ChemDiv Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record